🔵 ADVANCE YOUR RESEARCH WITH RETATRUTIDE 30MG

Premium Research Compound by Regenix Peptides

Explore the forefront of metabolic research with Retatrutide 30mg from Regenix Peptides.

Manufactured to rigorous quality standards, this high-purity lyophilized peptide is designed to support advanced laboratory investigations and preclinical research applications.

Retatrutide is an investigational triple receptor agonist currently being studied for its interaction with GLP-1, GIP, and glucagon receptor pathways, making it a valuable compound for researchers investigating:

🧬 Metabolic Regulation
⚡ Energy Expenditure
🩸 Glucose Homeostasis
🔬 Endocrine & Obesity Research

🧪 ABOUT RETATRUTIDE

Retatrutide is an investigational triple receptor agonist currently being studied for its potential effects on metabolic pathways, energy regulation, and glucose homeostasis. Due to its unique mechanism of action involving multiple receptor pathways, it has become a compound of significant scientific interest in preclinical research.

🔹 Triple GLP-1, GIP & Glucagon Receptor Agonist
🔹 Studied for Metabolic & Endocrine Research
🔹 Supports Advanced Scientific Investigations
🔹 Ideal for Preclinical & Laboratory Studies

⚠️ RESEARCH USE DISCLAIMER

FOR LABORATORY RESEARCH PURPOSES ONLY

This product is intended strictly for research and laboratory use only and is not for human consumption, therapeutic use, or diagnostic applications.